Live Breaking News & Updates on Architect Therapeutics

Stay updated with breaking news from Architect therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Elevation Oncology Announces Appointment of Darcy Mootz, Ph.D., to its Board of Directors

BOSTON, Jan. 22, 2024 /PRNewswire/ Elevation Oncology, Inc. (Nasdaq: ELEV), an innovative oncology company focused on the discovery and development of selective cancer therapies to treat patients across a ....

United States , Harvard University , Darcy Mootz , Head Of Amunix Pharmaceuticals , Duke University , Prnewswire Elevation Oncology Inc , Corporate Communications Investor Relations , Exchange Commission , Elevation Oncology Inc , Corporate Development At Achaogen , Elevation Oncology , Steve Elms , Managing Partner , Aisling Capital , Architect Therapeutics , Amunix Pharmaceuticals , Chief Business Officer , Vice President , Corporate Development , Elevation Oncology Board , Private Securities Litigation Reform Act , Oncology Investor , Corporate Communications ,

Elevation Oncology (ELEV) Appoints Darcy Mootz to its Board

Elevation Oncology (ELEV) Appoints Darcy Mootz to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Darcy Mootz , Duke University , Head Of Amunix Pharmaceuticals , Elevation Oncology Inc , Harvard University , Corporate Development At Achaogen , Elevation Oncology , Managing Partner , Aisling Capital , Architect Therapeutics , Amunix Pharmaceuticals , Chief Business Officer , Vice President , Corporate Development , Elevation Oncology Board ,